Endovalve Inc.

Large and small device companies alike are flocking to the large, undermet opportunity of mitral valve regurgitation. Most are focused on techniques for repairing damaged valves. Endovalve Inc. is the first to attempt to commercialize a percutaneous approach to replacing damaged mitral valves.

103 Carnegie Center

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight